APOGEE Medical, LLC, 40576 [E9-19298]
Download as PDF
40576
Federal Register / Vol. 74, No. 154 / Wednesday, August 12, 2009 / Notices
Elsewhere
in this issue of the Federal Register, the
Department has amended the definition
of the term consortium in the
regulations for the AIVRS program (34
CFR 371.4(b)). The purpose of this
regulatory change is to ensure that any
consortium of Indian tribes could
establish a separate legal entity to apply
for a grant under this program. Prior to
this regulatory change, the Department’s
definition of the term consortium under
the AIVRS program required Indian
tribes that choose to form a consortium
to designate one of the Indian tribes of
the consortium to serve as the grantee;
it did not also permit the Indian tribes
in the consortium to create a separate
legal entity that would serve as the
grantee on behalf of the consortium and
be responsible for using the grant funds
to provide services to all the Indian
tribes in the consortium. To ensure that
the change in the regulatory definition
of the term consortium under the AIVRS
program applies to entities applying for
a FY 2009 grant, we are reopening the
competition and establishing a new
deadline for the submission of
applications.
Only groups of Indian tribes that seek
to apply for funding under the AIVRS
program as a consortium using a
separate legal entity as the applicant are
permitted to submit an application
under this reopened competition.
Applicants that submitted applications
by the July 23, 2009, deadline date in
accordance with the terms of the May
14, 2009, notice inviting applications
are not required to submit new
applications. If an applicant that has
already submitted an application for
this competition now chooses to join a
consortium and have a separate legal
entity apply on behalf of the
consortium, the applicant must notify
the Department and reapply using the
separate legal entity as the applicant by
the deadline date in this notice.
The new deadline date is:
Deadline for Transmittal of
Applications: September 11, 2009.
For information (other than the
deadline for submission) about how to
submit your application, please refer to
section IV. 6. Other Submission
Requirements in the May 14, 2009
Federal Register notice (74 FR 22729).
Electronic Access to This Document:
You can view this document, as well as
all other documents of this Department
published in the Federal Register, in
text or Adobe Portable Document
Format (PDF) on the Internet at the
following site: https://www.ed.gov/news/
fedregister.
To use PDF you must have Adobe
Acrobat Reader, which is available free
jlentini on DSKJ8SOYB1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Nov<24>2008
16:38 Aug 11, 2009
Jkt 217001
at this site. If you have questions about
using PDF, call the U.S. Government
Printing Office (GPO), toll free, at 1–
888–293–6498; or in the Washington,
DC, area at (202) 512–1530.
Note: The official version of this document
is the document published in the Federal
Register. Free Internet access to the official
edition of the Federal Register and the Code
of Federal Regulations is available on GPO
Access at: https://www.gpoaccess.gov/nara/
index.html.
Delegation of Authority: The Secretary
of Education has delegated authority to
Andrew J. Pepin, Executive
Administrator for the Office of Special
Education and Rehabilitative Services,
to perform the functions of the Assistant
Secretary for Special Education and
Rehabilitative Services.
Dated: August 7, 2009.
Andrew J. Pepin,
Executive Administrator for Special
Education and Rehabilitative Services.
[FR Doc. E9–19333 Filed 8–11–09; 8:45 am]
BILLING CODE 4000–01–P
DEPARTMENT OF ENERGY
APOGEE Medical, LLC
Department of Energy.
Notice of intent to grant
exclusive patent license.
AGENCY:
ACTION:
SUMMARY: Notice is hereby given with
an intent to grant to APOGEE Medical,
LLC of Atlanta, Georgia, an exclusive
license to practice the inventions
described in U.S. Patent No. 5,413,596,
entitled ‘‘Digital Electronic Bone
Growth Stimulator.’’ The inventions are
owned by the United States of America,
as represented by the U.S. Department
of Energy (DOE).
DATES: Written comments or
nonexclusive license applications are to
be received at the address listed below
no later than August 27, 2009.
ADDRESSES: Office of the Assistant
General Counsel for Technology
Transfer and Intellectual Property, U.S.
Department of Energy, 1000
Independence Ave., SW., Washington,
DC 20585.
FOR FURTHER INFORMATION CONTACT:
Annette R. Reimers, Office of the
Assistant General Counsel for
Technology Transfer and Intellectual
Property, U.S. Department of Energy,
Forrestal Building, Room 6F–067, 1000
Independence Ave., SW., Washington,
DC 20585; Telephone (202) 586–3815.
SUPPLEMENTARY INFORMATION: 35 U.S.C.
209 provides Federal agencies with
authority to grant exclusive licenses in
federally-owned inventions, if, among
PO 00000
Frm 00016
Fmt 4703
Sfmt 4703
other things, the agency finds that the
public will be served by the granting of
the license. The statute requires that no
exclusive license may be granted unless
public notice of the intent to grant the
license has been provided, and the
agency has considered all comments
received in response to that public
notice before the end of the comment
period.
APOGEE Medical, LLC of Atlanta,
Georgia has applied for an exclusive
license to practice the inventions
embodied in U.S. Patent No. 5,413,596
and has plans for commercialization of
the inventions. The exclusive license
will be subject to a license and other
rights retained by the U.S. Government
and other terms and conditions to be
negotiated. DOE intends to negotiate to
grant the license, unless, within 15 days
of this notice, the Assistant General
Counsel for Technology Transfer and
Intellectual Property, Department of
Energy, Washington, DC 20585, receives
in writing any of the following, together
with supporting documents:
(i) A statement from any person
setting forth reason why it would not be
in the best interests of the United States
to grant the proposed license; or
(ii) An application for a nonexclusive
license to the invention in which
applicant states that it already has
brought the invention to practical
application or is likely to bring the
invention to practical application
expeditiously.
The Department will review all timely
written responses to this notice and will
proceed with negotiating the license if,
after consideration of written responses
to this notice, a finding is made that the
license is in the public interest.
Issued in Washington, DC, on August 6,
2009.
Paul A. Gottlieb,
Assistant General Counsel for Technology
Transfer and Intellectual Property.
[FR Doc. E9–19298 Filed 8–11–09; 8:45 am]
BILLING CODE 6450–01–P
DEPARTMENT OF ENERGY
Federal Energy Regulatory
Commission
[Docket No. CP09–451–000]
Tennessee Gas Pipeline Company;
Notice of Application
August 5, 2009.
Take notice that on July 31, 2009,
Tennessee Gas Pipeline Company
(Tennessee), 1001 Louisiana Street,
Houston, Texas 77002, filed in Docket
No. CP09–451–000, an application
E:\FR\FM\12AUN1.SGM
12AUN1
Agencies
[Federal Register Volume 74, Number 154 (Wednesday, August 12, 2009)]
[Notices]
[Page 40576]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-19298]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF ENERGY
APOGEE Medical, LLC
AGENCY: Department of Energy.
ACTION: Notice of intent to grant exclusive patent license.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given with an intent to grant to APOGEE
Medical, LLC of Atlanta, Georgia, an exclusive license to practice the
inventions described in U.S. Patent No. 5,413,596, entitled ``Digital
Electronic Bone Growth Stimulator.'' The inventions are owned by the
United States of America, as represented by the U.S. Department of
Energy (DOE).
DATES: Written comments or nonexclusive license applications are to be
received at the address listed below no later than August 27, 2009.
ADDRESSES: Office of the Assistant General Counsel for Technology
Transfer and Intellectual Property, U.S. Department of Energy, 1000
Independence Ave., SW., Washington, DC 20585.
FOR FURTHER INFORMATION CONTACT: Annette R. Reimers, Office of the
Assistant General Counsel for Technology Transfer and Intellectual
Property, U.S. Department of Energy, Forrestal Building, Room 6F-067,
1000 Independence Ave., SW., Washington, DC 20585; Telephone (202) 586-
3815.
SUPPLEMENTARY INFORMATION: 35 U.S.C. 209 provides Federal agencies with
authority to grant exclusive licenses in federally-owned inventions,
if, among other things, the agency finds that the public will be served
by the granting of the license. The statute requires that no exclusive
license may be granted unless public notice of the intent to grant the
license has been provided, and the agency has considered all comments
received in response to that public notice before the end of the
comment period.
APOGEE Medical, LLC of Atlanta, Georgia has applied for an
exclusive license to practice the inventions embodied in U.S. Patent
No. 5,413,596 and has plans for commercialization of the inventions.
The exclusive license will be subject to a license and other rights
retained by the U.S. Government and other terms and conditions to be
negotiated. DOE intends to negotiate to grant the license, unless,
within 15 days of this notice, the Assistant General Counsel for
Technology Transfer and Intellectual Property, Department of Energy,
Washington, DC 20585, receives in writing any of the following,
together with supporting documents:
(i) A statement from any person setting forth reason why it would
not be in the best interests of the United States to grant the proposed
license; or
(ii) An application for a nonexclusive license to the invention in
which applicant states that it already has brought the invention to
practical application or is likely to bring the invention to practical
application expeditiously.
The Department will review all timely written responses to this
notice and will proceed with negotiating the license if, after
consideration of written responses to this notice, a finding is made
that the license is in the public interest.
Issued in Washington, DC, on August 6, 2009.
Paul A. Gottlieb,
Assistant General Counsel for Technology Transfer and Intellectual
Property.
[FR Doc. E9-19298 Filed 8-11-09; 8:45 am]
BILLING CODE 6450-01-P